ArticleFrontiers in immunology2018

HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy.

Diana P Saraiva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.